Publications by authors named "Mario Caccese"

Claim this Profile
C
Clinical presentation, predictive factors and management of patients with Nelson syndrome: a retrospective study.
Pierluigi Mazzeo, Giulia Bovo, Alessandro Mondin, Giacomo Voltan, Renzo Manara, Mario Caccese

Pituitary· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib versus local standard of care in patients with grade 2-3 meningioma no longer eligible for loco-regional treatments: a phase II randomized controlled trial (the MIRAGE study).
Alberto Bosio, Giulia Cerretti, Marta Padovan, Paola Del Bianco, Maurizio Polano, Mario Caccese

Trials· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab in recurrent glioblastoma: does dose matter? Our monocentric and comparative experience.
Giulia Cerretti, Alberto Bosio, Giovanni Librizzi, Giovanna Pintacuda, Mario Caccese

J Neurooncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Texture analysis can predict response to etoposide-doxorubicin-cisplatin in patients with adrenocortical carcinoma.
Filippo Crimì, Francesca Turatto, Carlo D'Alessandro, Giovanni Sussan, Maurizio Iacobone, Mario Caccese

J Endocrinol Invest· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives" [Cancer Treat. Rev. 131 (2024) 102850].
Eugenia Cella, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan

Cancer Treat Rev· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectives.
Eugenia Cella, Alberto Bosio, Pasquale Persico, Mario Caccese, Marta Padovan

Cancer Treat Rev· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local therapy in glioma: An evolving paradigm from history to horizons (Review).
Tamara Ius, Teresa Somma, Francesco Pasqualetti, Jacopo Berardinelli, Francesca Vitulli, Mario Caccese

Oncol Lett· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged response to entrectinib in an adult patient with recurrent glioblastoma harboring a fusion.
Giulia Cerretti, Marta Padovan, Angela Guerriero, Marta Maccari, Alberto Bosio, Mario Caccese

Neurooncol Adv· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Present and Future of Immunotherapy in Patients With Glioblastoma: Limitations and Opportunities.
Marta Maccari, Chooyoung Baek, Mario Caccese, Susanna Mandruzzato, Alba Fiorentino

Oncologist· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of adjuvant chemotherapy in patients with H3K27 altered diffuse midline gliomas: a multicentric retrospective study.
Vincenzo Di Nunno, Giuseppe Lombardi, Matteo Simonelli, Giuseppe Minniti, Angela Mastronuzzi, Mario Caccese

J Neurooncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glioblastoma and Internal Carotid Artery Calcium Score: A Possible Novel Prognostic Partnership?
Francesco Pasqualetti, Michela Gabelloni, Lorenzo Faggioni, Giovanni Donato Aquaro, Fabrizio De Vietro, Mario Caccese

J Clin Med· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of chlorpromazine as an adjuvant therapy for glioblastoma in patients with unmethylated gene promoter: RACTAC, a phase II multicenter trial.
Andrea Pace, Giuseppe Lombardi, Veronica Villani, Dario Benincasa, Claudia Abbruzzese, Mario Caccese

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spinal ependymoma in adults: from molecular advances to new treatment perspectives.
Giulia Cerretti, Federico Pessina, Enrico Franceschi, Valeria Barresi, Alessandro Salvalaggio, Mario Caccese

Front Oncol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Actionable molecular alterations in newly diagnosed and recurrent IDH1/2 wild-type glioblastoma patients and therapeutic implications: a large mono-institutional experience using extensive next-generation sequencing analysis.
Marta Padovan, Marta Maccari, Alberto Bosio, Chiara De Toni, Salvatore Vizzaccaro, Mario Caccese

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: The lesson from opioid withdrawal symptoms mimicking paraganglioma recurrence during opioid deprescribing in cancer pain.
Elena Ruggiero, Ardi Pambuku, Mario Caccese, Giuseppe Lombardi, Ivan Gallio

Front Pain Res (Lausanne)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of radiation therapy and systemic treatments in meningioma: The present and the future.
Mario Caccese, Fabio Busato, Angela Guerriero, Marta Padovan, Giulia Cerretti

Cancer Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
Mario Caccese, Isacco Desideri, Marta Padovan, Francesco Bruno, Giulia Cerretti

J Neurooncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigen rapid diagnostic test monitoring for SARS-CoV-2 in asymptomatic and fully vaccinated cancer patients: Is it cost-effective?
Mario Caccese, Anna Maria Saieva, Valentina Guarneri, Sara Lonardi, Massimo Cacco

Cancer Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowing when to discontinue Temozolomide therapy in responding aggressive pituitary tumors and carcinomas: a systematic review and Padua (Italy) case series.
Marta Padovan, Giulia Cerretti, Mario Caccese, Mattia Barbot, Eleonora Bergo

Expert Rev Endocrinol Metab· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impressive response to dabrafenib and trametinib plus silybin in a heavily pretreated IDH wild-type glioblastoma patient with BRAFV600E -mutant and SOX2 amplification.
Giulia Cerretti, Diego Cecchin, Luca Denaro, Mario Caccese, Marta Padovan

Anticancer Drugs· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Adrenocortical Carcinoma: From Symptoms Control to Palliative Care.
Elena Ruggiero, Irene Tizianel, Mario Caccese, Giuseppe Lombardi, Ardi Pambuku

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous care in oncology: Assessment of benefit in relation to symptoms, sex, and age in 753 patients.
Antonella Galiano, Stefania Schiavon, Mariateresa Nardi, Irene Guglieri, Ardi Pambuku, Mario Caccese

Front Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Overall Survival and Progression-Free Survival in Patients with Advanced Adrenocortical Cancer Is Increased after the Multidisciplinary Team Evaluation.
Irene Tizianel, Mario Caccese, Francesca Torresan, Giuseppe Lombardi, Laura Evangelista

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Definition of the Prognostic Role of MGMT Promoter Methylation Value by Pyrosequencing in Newly Diagnosed IDH Wild-Type Glioblastoma Patients Treated with Radiochemotherapy: A Large Multicenter Study.
Mario Caccese, Matteo Simonelli, Veronica Villani, Simona Rizzato, Tamara Ius

Cancers (Basel)· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Innovating Strategies and Tailored Approaches in Neuro-Oncology.
Alberto Picca, David Guyon, Orazio Santo Santonocito, Capucine Baldini, Ahmed Idbaih, Mario Caccese

Cancers (Basel)· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis